Beta-catenin dysregulation in thyroid neoplasms: down-regulation, aberrant nuclear expression, and CTNNB1 exon 3 mutations are markers for aggressive tumor phenotypes and poor prognosis.

Source:http://linkedlifedata.com/resource/pubmed/id/11238046

Download in:

View as

General Info

PMID
11238046